title: Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection.
abstract: Zidovudine is an important component of first-line antiretroviral treatment regimens used to manage HIV and tuberculosis (TB) co-infection. Nail pigmentation is documented both in adult as well as pediatric HIV patients, but to the best of our knowledge, it has not been reported in 45-year-old women of HIV/TB co-infection. Such an adverse drugs reactions (ADR), although is harmless and reversible, psychological aspects of such ADR may be immense to the extent that it can negatively affect the compliance and result in therapeutic failure. Thus, it is worth reporting.
authors.affiliation: Department of Pharmacology and Therapeutics, Government Medical College, Jammu City, Jammu and Kashmir, India.
authors.forename: Vishal R
authors.initials: VR
authors.lastname: Tandon
authors.affiliation: Department of Pharmacology, Government Medical College, Jammu City, Jammu and Kashmir, India.
authors.forename: Shamiya
authors.initials: S
authors.lastname: Sadiq
authors.affiliation: Department of Pharmacology, Government Medical College, Jammu City, Jammu and Kashmir, India.
authors.forename: Vijay
authors.initials: V
authors.lastname: Khajuria
authors.affiliation: Department of Internal Medicine, Government Medical College, Jammu City, Jammu and Kashmir, India.
authors.forename: Annil
authors.initials: A
authors.lastname: Mahajan
authors.affiliation: Department of Obstetrics and Gynecology, Government Medical College, Jammu City, Jammu and Kashmir, India.
authors.forename: Sudhaa
authors.initials: S
authors.lastname: Sharma
authors.affiliation: Department of Pharmacology, Government Medical College, Jammu City, Jammu and Kashmir, India.
authors.forename: Zahid
authors.initials: Z
authors.lastname: Gillani
keywords: Adverse drugs reactions; HIV and tuberculosis co-infection; Zidovudine; nail hyper-pigmentation